Stock Movers of Note: Anadys Pharmaceuticals, Elan Corp., and Shopping.com Emerge as Top Stock Gainers

In the stock market, significant movements often follow key announcements and partnerships. Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) witnessed a noteworthy 25.74% surge as it entered into an exclusive global license and co-development agreement with Novartis (NYSE: NVS). This partnership aims to develop, manufacture, and commercialize ANA975 and additional Toll-Like Receptor 7 oral prodrugs. Additionally, Shopping.com (Nasdaq: SHOP) saw a substantial 18.98% increase after eBay (Nasdaq: EBAY) agreed to acquire the company for $21 per share in cash, amounting to approximately $620 million. Meanwhile, Elan Corp. (NYSE: ELN) experienced a 16.77% decline following reports of a fourth patient taking its MS drug Tysabri possibly contracting a deadly brain disease.

Key Takeaways:

Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) stock surged by 25.74% due to its partnership with Novartis (NYSE: NVS) for the development and commercialization of oral prodrugs.
Shopping.com (Nasdaq: SHOP) shares increased by 18.98% after eBay (Nasdaq: EBAY) agreed to acquire the company for approximately $620 million.
Elan Corp. (NYSE: ELN) stock dropped by 16.77% due to concerns over the safety of its MS drug Tysabri.
Dobson Communications (Nasdaq: DCEL) saw a 15.10% increase in stock value, likely due to the company's positive update from the SEC inquiry.
Novartis (NYSE: NVS) and eBay (Nasdaq: EBAY) have been instrumental in driving significant stock movement through their partnerships.

Statistics:

Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) stock increase: 25.74%.
Shopping.com (Nasdaq: SHOP) stock increase: 18.98%.
Elan Corp. (NYSE: ELN) stock decrease: 16.77%.
Dobson Communications (Nasdaq: DCEL) stock increase: 15.10%.
Acquisition price by eBay (Nasdaq: EBAY): $21 per share in cash.
Acquisition amount: Approximately $620 million.

Sources:

StreetInsider.com (http://www.streetinsider.com)